Daesang Corporation (KRX:001680)
South Korea · Delayed Price · Currency is KRW 20,050
+330 (1.67%)
Last updated: Apr 8, 2026, 2:06 PM KST
Daesang Revenue
In the year 2025, Daesang had annual revenue of 4.40T KRW with 3.44% growth. Daesang had revenue of 1.05T in the quarter ending December 31, 2025, with 0.46% growth.
Revenue
4.40T
Revenue Growth
+3.44%
P/S Ratio
0.16
Revenue / Employee
871.55M
Employees
5,050
Market Cap
683.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.40T | 146.17B | 3.44% |
| Dec 31, 2024 | 4.26T | 147.64B | 3.59% |
| Dec 31, 2023 | 4.11T | 23.40B | 0.57% |
| Dec 31, 2022 | 4.08T | 614.10B | 17.70% |
| Dec 31, 2021 | 3.47T | 356.79B | 11.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harim Holdings | 13.21T |
| Daesang Holdings | 5.63T |
| Otoki | 3.67T |
| EASY HOLDINGS | 3.39T |
| Pulmuone Corporate | 3.38T |
| SPC Samlip | 3.37T |
| Samyang | 2.56T |
| Kwang Dong Pharmaceutical | 1.66T |